Recruiting Clinical Trials

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma

By April 24, 2017 No Comments


Malignant Pleural Mesothelioma

Estimated Enrollment: 6

Age Group: 18 Years to 75 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: FAPME-1

Study First Received: October 31, 2012

Last Updated: May 10, 2016

Estimated Primary Completion Date: December 2016


Primary Outcome Measures:


Sponsors and Collaborators:

University of Zurich

Website Link:

Leave a Reply

Call Now